Schedule 13D ownership disclosure

N/A

Common Stock, par value $0.001 per share · CUSIP: 14179K101

Event date: 2025-08-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621

    Shares: 10,000.00 · Class: 100%

  • KEVIN TANGReported CIK 0001178579

    Shares: 10,000.00 · Class: 100%

  • TANG CAPITAL PARTNERS, LPReported CIK 0001191935

    Shares: 10,000.00 · Class: 100%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LPReported CIK 0002064011

    Shares: 0.00 · Class: 0%

  • TANG CAPITAL PARTNERS III, INCReported CIK 0002036763

    Shares: 0.00 · Class: 0%

  • TANG CAPITAL PARTNERS IV, INCReported CIK 0002036770

    Shares: 0.00 · Class: 0%

  • CONCENTRA BIOSCIENCES, LLCReported CIK 0001970065

    Shares: 10,000.00 · Class: 100%

  • CONCENTRA MERGER SUB VII, INC.

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-012545
Form type
SCHEDULE 13D/A
Filer
CARGO Therapeutics, Inc.
CIK
CIK 1966494
Filed
Aug 21, 2025
Reporting period
Aug 19, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub